Our findings provide evidence that microRNA-195 attenuates epithelial-mesenchymal transition (EMT) in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1 and strongly suggest that overexpression of miR-195 may have therapeutic value in treating breast cancer. This evidence concerns the gene CYP27B1 and breast carcinoma.